A Stock Rating Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : A Stock Rating Thread

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: PartyTime who wrote ()	8/28/1999 4:00:00 PM
From: PartyTime	Read Replies (2) of 83

BTRN--92 % overall indicator buy. equities.barchart.com From an August 16, 1999 press release: "....BioTransplant Incorporated utilizes its proprietary technologies in re-educating the body's immune responses to allow tolerance of foreign cells, tissues and organs. Based on this ImmunoCognance(TM) technology, the Company is developing a portfolio of products designed to treat a range of medical conditions, including organ and tissue transplantation, cancer and autoimmune disease, for which current therapies are inadequate. BioTransplant's products are intended to induce long-term functional transplantation tolerance in humans, increase the therapeutic benefit of bone marrow transplants, and reduce or eliminate the need for lifelong immunosuppressive therapy...." NOTE: I haven't thoroughly DD'd this one yet. I only discovered it while seeking an example to get this new thread off the ground.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext